Singapore-based Inex Innovations Exchange has expanded its iGeneScreen noninvasive prenatal test to include fetal sex chromosome abnormalities, in addition to trisomy 21, 18, and 13. Inex developed its next-generation sequencing-based iGeneScreen test in collaboration with BGI.
New Products: Inex Innovations Exchange's iGeneScreen
May 22, 2013
Premium
What's Popular?